3 results match your criteria: "Baylor Heart and Vascular Hospital at Baylor University Medical Center[Affiliation]"
Percutaneous Retrieval of an Embolized Amulet Device From the Aorta Using a Novel Retrieval System.
JACC Clin Electrophysiol
December 2024
Baylor Heart and Vascular Hospital at Baylor University Medical Center, Dallas, Texas, USA.
Five-Year Clinical Outcomes of the COBRA Polyzene F NanoCoated Coronary Stent System.
Cardiovasc Revasc Med
August 2022
Department of Cardiology, Heart Center at the Isar, Munich, Germany.
Background/purpose: The COBRA Polyzene F™ NanoCoated Coronary Stent System (PzF coated stent) stent demonstrated favorable clinical outcomes at 9 months but late results have not been reported. We sought to assess the late safety and effectiveness of the PzF coated stent for treatment of de novo coronary artery lesions.
Methods: Patients with de novo coronary artery lesions meeting eligibility criteria were enrolled in a non-randomized, prospective clinical trial and followed for 5 years.
9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System.
JACC Cardiovasc Interv
January 2017
CeloNova BioSciences, San Antonio, Texas.
Objectives: The aim of this study was to assess the safety and effectiveness of the COBRA Polyzene-F NanoCoated Coronary Stent System (CeloNova Biosciences, San Antonio, Texas) for the treatment of de novo coronary artery lesions.
Background: Polyzene-F-coated coronary stents have shown reduced thrombogenicity and inflammation in preclinical studies.
Methods: Patients with de novo coronary artery lesions meeting eligibility criteria were enrolled in a nonrandomized, prospective clinical trial.